Ying Chao

651 total citations
19 papers, 358 citations indexed

About

Ying Chao is a scholar working on Molecular Biology, Surgery and Neurology. According to data from OpenAlex, Ying Chao has authored 19 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Surgery and 3 papers in Neurology. Recurrent topics in Ying Chao's work include Cancer, Lipids, and Metabolism (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Cholesterol and Lipid Metabolism (3 papers). Ying Chao is often cited by papers focused on Cancer, Lipids, and Metabolism (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Cholesterol and Lipid Metabolism (3 papers). Ying Chao collaborates with scholars based in China, United States and Australia. Ying Chao's co-authors include Qinghai Meng, Huimin Bian, Qi Chen, Xichao Yu, Cheng Peng, Tingting Ji, Qichun Zhang, Yu Li, Haijun Yu and Zeyi Xiao and has published in prestigious journals such as Bioresource Technology, Biochemical Pharmacology and Life Sciences.

In The Last Decade

Ying Chao

17 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Chao China 9 177 51 48 46 45 19 358
Mohammad Rafi Khezri Iran 13 182 1.0× 28 0.5× 85 1.8× 28 0.6× 42 0.9× 35 497
Run Li China 12 100 0.6× 67 1.3× 41 0.9× 39 0.8× 35 0.8× 45 546
Hae-Jin Park South Korea 13 120 0.7× 43 0.8× 48 1.0× 42 0.9× 23 0.5× 66 483
Mario Guzmán Spain 11 124 0.7× 150 2.9× 30 0.6× 49 1.1× 30 0.7× 23 490
Tingting Bao China 14 211 1.2× 40 0.8× 42 0.9× 55 1.2× 19 0.4× 35 588
Y. Muto Japan 10 98 0.6× 29 0.6× 127 2.6× 31 0.7× 30 0.7× 24 423
Xiaohan Li China 13 233 1.3× 44 0.9× 32 0.7× 31 0.7× 26 0.6× 40 451
Farzaneh Rostamzadeh Iran 13 151 0.9× 60 1.2× 71 1.5× 31 0.7× 24 0.5× 40 452
Shuren Guo China 14 208 1.2× 63 1.2× 21 0.4× 50 1.1× 6 0.1× 35 483
Jiaxing Zhang China 14 220 1.2× 36 0.7× 84 1.8× 95 2.1× 23 0.5× 29 575

Countries citing papers authored by Ying Chao

Since Specialization
Citations

This map shows the geographic impact of Ying Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Chao more than expected).

Fields of papers citing papers by Ying Chao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Chao. The network helps show where Ying Chao may publish in the future.

Co-authorship network of co-authors of Ying Chao

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Chao. A scholar is included among the top collaborators of Ying Chao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Chao. Ying Chao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Tian, Peng, et al.. (2025). Assessing compound exposure of vulnerable populations under dual inequality of urban heatwaves and green space. Sustainable Cities and Society. 134. 106951–106951.
3.
Chao, Ying, Hui Zhang, Ting Wang, et al.. (2024). Plasma level of alpha-synuclein oligomers as a biomarker for isolated rapid eye movement sleep behavior disorder diagnosis and progression: a prospective cohort study. Frontiers in Neurology. 15. 1442173–1442173. 1 indexed citations
4.
Chao, Ying, et al.. (2024). Probing the diagnostic values of plasma cf-nDNA and cf-mtDNA for Parkinson’s disease and multiple system atrophy. Frontiers in Neuroscience. 18. 1488820–1488820. 3 indexed citations
5.
Chao, Ying, Chao Han, Yuan Li, et al.. (2024). Plasma circulating cell–free DNA integrity and relative telomere length as diagnostic biomarkers for Parkinson’s disease and multiple system atrophy: a cross-sectional study. Neural Regeneration Research. 20(12). 3553–3563. 1 indexed citations
6.
Meng, Qinghai, Ying Chao, Shurui Zhang, et al.. (2023). Attenuation of estrogen and its receptors in the post-menopausal stage exacerbates dyslipidemia and leads to cognitive impairment. Molecular Brain. 16(1). 80–80. 13 indexed citations
7.
Zhang, Mingkai, Xiaoni Wang, Weina Zhao, et al.. (2023). Subjective cognitive decline domain improves accuracy of plasma Aβ42/Aβ40 for preclinical Alzheimer's disease diagnosis: The SILCODE study. Chinese Medical Journal. 137(9). 1127–1129. 4 indexed citations
8.
Fu, Yu, Han Feng, Qinghai Meng, et al.. (2022). Alisol B 23-acetate adjusts bile acid metabolisim via hepatic FXR-BSEP signaling activation to alleviate atherosclerosis. Phytomedicine. 101. 154120–154120. 29 indexed citations
9.
Meng, Kangkang, et al.. (2021). Evaluation of illness severity of neonate infectious pneumonia and neurobehavioral development through ultrasonography under adaption algorithm. Pakistan Journal of Medical Sciences. 37(6-WIT). 1682–1686. 2 indexed citations
11.
Li, Jun, Qinghai Meng, Yu Fu, et al.. (2021). Novel insights: Dynamic foam cells derived from the macrophage in atherosclerosis. Journal of Cellular Physiology. 236(9). 6154–6167. 37 indexed citations
12.
Chen, Qi, Ying Chao, Weiwei Zhang, et al.. (2020). Activation of estrogen receptor α (ERα) is required for Alisol B23-acetate to prevent post-menopausal atherosclerosis and reduced lipid accumulation. Life Sciences. 258. 118030–118030. 18 indexed citations
13.
Meng, Qinghai, Xu Qi, Ying Chao, et al.. (2020). IRS1/PI3K/AKT pathway signal involved in the regulation of glycolipid metabolic abnormalities by Mulberry (Morus alba L.) leaf extracts in 3T3-L1 adipocytes. Chinese Medicine. 15(1). 1–1. 70 indexed citations
14.
Meng, Qinghai, Jun Li, Ying Chao, et al.. (2020). β-estradiol adjusts intestinal function via ERβ and GPR30 mediated PI3K/AKT signaling activation to alleviate postmenopausal dyslipidemia. Biochemical Pharmacology. 180. 114134–114134. 26 indexed citations
15.
Yu, Xichao, Yu Fu, Weiwei Zhang, et al.. (2020). Alisol B 23-acetate activates ABCG5/G8 in the jejunum via the LXRα/ACAT2 pathway to relieve atherosclerosis in ovariectomized ApoE-/- mice. Aging. 12(24). 25744–25766. 8 indexed citations
16.
Huang, Jianbo, et al.. (2018). Effects of mulberry leaf on experimental hyperlipidemia rats induced by high‑fat diet. Experimental and Therapeutic Medicine. 16(2). 547–556. 31 indexed citations
17.
Lei, Xiujuan, Ying Chao, Fang‐Xiang Wu, & Jin Xu. (2015). Clustering PPI data by combining FA and SHC method. BMC Genomics. 16(S3). S3–S3. 7 indexed citations
18.
Chen, Chunyan, Zeyi Xiao, Xiaoyu Tang, et al.. (2012). Acetone–butanol–ethanol fermentation in a continuous and closed-circulating fermentation system with PDMS membrane bioreactor. Bioresource Technology. 128. 246–251. 56 indexed citations
19.
Liang, Jie, Ying Chao, M. O. Manasreh, E. Marega, & Gregory J. Salamo. (2005). Broad-band photoresponse from InAs quantum dots embedded into InGaAs graded well. IEEE Electron Device Letters. 26(9). 631–633. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026